Cargando…

Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the leading global causes of cancer mortality. MicroRNAs (miRNAs) are small interfering RNAs that alleviate the levels of protein expression by suppressing translation, inducing mRNA cleavage, and promoting mRNA degradation. miR-122 is the most abundant miRNA...

Descripción completa

Detalles Bibliográficos
Autor principal: Chun, Kwang-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316959/
https://www.ncbi.nlm.nih.gov/pubmed/35890276
http://dx.doi.org/10.3390/pharmaceutics14071380
_version_ 1784754940800925696
author Chun, Kwang-Hoon
author_facet Chun, Kwang-Hoon
author_sort Chun, Kwang-Hoon
collection PubMed
description Hepatocellular carcinoma (HCC) is one of the leading global causes of cancer mortality. MicroRNAs (miRNAs) are small interfering RNAs that alleviate the levels of protein expression by suppressing translation, inducing mRNA cleavage, and promoting mRNA degradation. miR-122 is the most abundant miRNA in the liver and is responsible for several liver-specific functions, including metabolism, cellular growth and differentiation, and hepatitis virus replication. Recent studies have shown that aberrant regulation of miR-122 is a key factor contributing to the development of HCC. In this review, the signaling pathways and the molecular targets of miR-122 involved in the progression of HCC have been summarized, and the importance of miR-122 in therapy has been discussed.
format Online
Article
Text
id pubmed-9316959
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93169592022-07-27 Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma Chun, Kwang-Hoon Pharmaceutics Review Hepatocellular carcinoma (HCC) is one of the leading global causes of cancer mortality. MicroRNAs (miRNAs) are small interfering RNAs that alleviate the levels of protein expression by suppressing translation, inducing mRNA cleavage, and promoting mRNA degradation. miR-122 is the most abundant miRNA in the liver and is responsible for several liver-specific functions, including metabolism, cellular growth and differentiation, and hepatitis virus replication. Recent studies have shown that aberrant regulation of miR-122 is a key factor contributing to the development of HCC. In this review, the signaling pathways and the molecular targets of miR-122 involved in the progression of HCC have been summarized, and the importance of miR-122 in therapy has been discussed. MDPI 2022-06-29 /pmc/articles/PMC9316959/ /pubmed/35890276 http://dx.doi.org/10.3390/pharmaceutics14071380 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Chun, Kwang-Hoon
Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
title Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
title_full Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
title_fullStr Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
title_full_unstemmed Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
title_short Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
title_sort molecular targets and signaling pathways of microrna-122 in hepatocellular carcinoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316959/
https://www.ncbi.nlm.nih.gov/pubmed/35890276
http://dx.doi.org/10.3390/pharmaceutics14071380
work_keys_str_mv AT chunkwanghoon moleculartargetsandsignalingpathwaysofmicrorna122inhepatocellularcarcinoma